Newsroom
-
Mammoth Biosciences Secures Award to Develop CRISPR-based Diagnostics and Biosurveillance Platforms
WebWireLearn More -
Mammoth Biosciences Signs Agreements with MilliporeSigma and Hamilton Company Targeting Commercialization of High-Throughput CRISPR-based SARS CoV-2 Test
WebWireLearn More -
Mammoth Biosciences Co-Founder Professor Jennifer Doudna Wins Nobel Prize in Chemistry for CRISPR Discovery
WebWireLearn More -
Mammoth Biosciences Named to the 2020 CB Insights 150 Most Innovative Digital Health Startups List
WebWireLearn More -
Mammoth Biosciences Further Strengthens IP Portfolio with Exclusive License to Novel Micro-Sized CRISPR Proteins
WebWireLearn More -
Mammoth Biosciences Secures Contract from National Institutes of Health to Scale Its High-Throughput CRISPR SARS-CoV-2 Diagnostic Platform to Address Testing Capacity Shortages
WebWireLearn More -